R. Andrew Eckert


About R. Andrew Eckert

R. Andrew Eckert serves as a director of BD (Becton, Dickinson and Company), a global medical technology company headquartered in Franklin Lakes, New Jersey. Eckert has been a member of the board since 2016.

Mr. Eckert serves as a senior advisor to Permira, a global private equity firm, since December 2022.  From August 2020 to August 2021, Mr. Eckert served as chief executive officer (CEO) of Zelis Inc., a provider of healthcare cost management and payments solutions. From 2017 until the sale of the company in October 2019, he served as president and CEO of Acelity L.P. Inc., a global wound care company. From 2015 until 2016, Eckert served as CEO of Valence Health, Inc., a healthcare information technology and services company. Prior thereto, he served as CEO of TriZetto Corporation, a healthcare information technology solutions firm, and CEO of CRC Health Group, a provider of specialized behavioral healthcare services.  Eckert also serves as a director of Vyaire Medical Inc. and served as chairman of Varian Medical Systems Inc.

Eckert is a leader in the growing field of healthcare information technology, with extensive experience as an executive officer of several healthcare companies. He has a deep knowledge of operations, strategic planning, product development and marketing and has valuable corporate governance insight gained from having served as a director of several public companies.